Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

Identifying differences in the intestinal microbiome between healthy, inflammatory bowel disease (IBD), and IBD-associated colorectal cancer, that mediate dietary fibre-associated inflammation

FY 2022-23

Summary
Incidence of the severe and chronic inflammatory bowel diseases (IBD) is increasing and yet the cause remains unknown. Diet and the gut microbiome (bacteria, fungi, and viruses) play a role. Specifically, dietary fibres are not digested; instead, they require gut microbes to ferment them into short-chain fatty acids (SCFAs) which can heal and protect the gut. However, patients with IBD have different types and amounts of gut microbes and often have reduced SCFA. This suggests that fibre fermentation is limited in IBD patients. Interestingly, many IBD patients express intolerance to a high-fibre diet which can cause patients to avoid eating fibre. These exclusion diets can improve symptoms but deprive the patients of essential nutrients. This previously led us to investigate what happens if fibres are not fermented in the IBD gut. We found one type of fibre (?-fructan; found in asparagus, artichoke, banana, and other foods) causes gut damage in IBD if it is not broken down by the microbes. Sustained gut damage in IBD patients increases their risk of developing colon cancer (CRC) however, how this happens is not well understood. I have uncovered that unfermented ?-fructan fibres can increase pathways associated with CRC. Based on my preliminary findings I hypothesize that in IBD patients whose gut microbes cannot ferment ?-fructans, these unfermented ?-fructans cause tumorigenesis and disease progression to CRC. My research project will determine if this diet induced inflammation in select IBD patients worsens IBD symptoms or if consumption of ?-fructans in IBD patients whose gut microbiota are not able to ferment ?-fructans leads to increased risk of CRC. These findings will help guide the personalized dietary fibre advice we give to IBD patients in a clinical setting.
Program
Master's Award: Canada Graduate Scholarships
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486052
Name
Voisin Athalia S
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying differences in the intestinal microbiome between healthy, inflammatory bowel disease (IBD), and IBD-associated colorectal cancer, that mediate dietary fibre-associated inflammation
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Colorectal Cancer; Crohn Disease; Diet; Dietary Fibre; Dysbiosis; Inflammation; Inflammatory Bowel Diseases; Microbiome; Ulcerative Colitis; ß­-Fructan
Abstract
Incidence of the severe and chronic inflammatory bowel diseases (IBD) is increasing and yet the cause remains unknown. Diet and the gut microbiome (bacteria, fungi, and viruses) play a role. Specifically, dietary fibres are not digested; instead, they require gut microbes to ferment them into short-chain fatty acids (SCFAs) which can heal and protect the gut. However, patients with IBD have different types and amounts of gut microbes and often have reduced SCFA. This suggests that fibre fermentation is limited in IBD patients. Interestingly, many IBD patients express intolerance to a high-fibre diet which can cause patients to avoid eating fibre. These exclusion diets can improve symptoms but deprive the patients of essential nutrients. This previously led us to investigate what happens if fibres are not fermented in the IBD gut. We found one type of fibre (?-fructan; found in asparagus, artichoke, banana, and other foods) causes gut damage in IBD if it is not broken down by the microbes. Sustained gut damage in IBD patients increases their risk of developing colon cancer (CRC) however, how this happens is not well understood. I have uncovered that unfermented ?-fructan fibres can increase pathways associated with CRC. Based on my preliminary findings I hypothesize that in IBD patients whose gut microbes cannot ferment ?-fructans, these unfermented ?-fructans cause tumorigenesis and disease progression to CRC. My research project will determine if this diet induced inflammation in select IBD patients worsens IBD symptoms or if consumption of ?-fructans in IBD patients whose gut microbiota are not able to ferment ?-fructans leads to increased risk of CRC. These findings will help guide the personalized dietary fibre advice we give to IBD patients in a clinical setting.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Voisin, Athalia S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~
University of Manitoba - $17,500 Grant (2022-23) | Canada Spends